36 Participants Needed

Robotic Ankle Therapy for Cerebral Palsy

ZL
Overseen ByZach Lerner, PhD
Age: < 65
Sex: Any
Trial Phase: Phase 1
Sponsor: Northern Arizona University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests new robotic ankle devices to help children with cerebral palsy (CP) improve their walking. Researchers compare the effects of robotic ankle resistance and assistance (Biomotum Spark) against standard therapies to determine which works best. They examine how these devices might enhance muscle control, gait, and overall mobility. Children with CP who have ankle-related walking issues and can walk at least 30 feet might be suitable candidates. The study aims to find better ways to boost movement and endurance during everyday activities. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this innovative therapy.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications, but it does mention that you cannot have concurrent treatment other than those assigned during the study. It's best to discuss your specific medications with the trial coordinators.

What prior data suggests that this robotic ankle therapy is safe for children with cerebral palsy?

Research shows that robotic ankle devices, such as the Biomotum Spark, have been tested to assist people with cerebral palsy. Studies have found that these devices can improve walking and ease movement. Initial tests of the Biomotum Spark's robotic ankle support demonstrated that users experienced better mobility and found walking on various surfaces, like flat ground and stairs, less tiring.

Regarding the robotic ankle's resistance feature, past research focused on ensuring its safety and effectiveness. Tests aimed to enhance overall walking and movement. These tests found that the devices were generally well-received, with no major safety issues.

Since this trial is in the early stages, it primarily assesses the treatment's safety and how well people adapt to it. At this point, researchers closely monitor any new treatment to ensure it doesn’t cause harm, but there is limited information on long-term effects. Participants can expect a thorough evaluation to ensure safety.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these robotic ankle therapies for cerebral palsy because they offer a new approach to improving mobility. Unlike traditional physical therapy and ankle braces, which primarily support or stabilize the ankle, the Biomotum Spark device provides both adaptive assistance and resistance during movement. This means it can dynamically help or challenge the muscles, potentially enhancing muscle strength and coordination more effectively. By targeting specific muscle groups with precision, these treatments aim to improve walking ability in ways that standard treatments may not.

What evidence suggests that this trial's treatments could be effective for cerebral palsy?

Research shows that robotic ankle support can significantly improve mobility for people with cerebral palsy. In this trial, participants may use the Biomotum Spark device, which offers both support and resistance. Studies have found that this technology eases walking and reduces fatigue by lowering ankle strain by 12%, especially when walking uphill. Additionally, robotic ankle resistance training can enhance walking speed, distance, and step length. This approach helps build muscle strength and improve walking patterns. The Biomotum Spark device aims to enhance strength and movement skills, showing promising early results for children with CP.13678

Who Is on the Research Team?

ZF

Zach F Lerner, PhD

Principal Investigator

Northern Arizona University

Are You a Good Fit for This Trial?

This trial is for children aged 8-18 with Cerebral Palsy who have trouble walking due to ankle issues. They must be able to follow simple instructions and walk at least 30 feet, with or without help. Kids who've had other treatments or surgeries within the last 6 months can't join.

Inclusion Criteria

I can follow simple instructions and walk at least 30 feet, with or without help.
I can point my toes downward at least 20 degrees.
I am between 8 and 21 years old with CP and ankle problems affecting my walk.

Exclusion Criteria

I have not had surgery in the last 6 months.
Concurrent treatment other than those assigned during the study
A condition other than CP that would affect safe participation

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo targeted ankle resistance gait training and adaptive ankle assistance for 12 weeks

12 weeks
2 visits/week

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Ankle foot orthosis
  • Biomotum Spark: Robotic ankle assistance
  • Biomotum Spark: Robotic ankle resistance
  • Standard gait training
  • Standard physical therapy
  • Standard walking
Trial Overview The study tests if special gait training with robotic ankle assistance or resistance improves walking in kids with CP better than standard therapy. It checks their muscle control and mobility after four and twelve weeks, comparing it to regular physical therapy and walking aids.
How Is the Trial Designed?
6Treatment groups
Experimental Treatment
Group I: Standard gait training (control)Experimental Treatment1 Intervention
Group II: Passive brace assisted ambulationExperimental Treatment1 Intervention
Group III: No ankle aid ambulationExperimental Treatment1 Intervention
Group IV: Device resisted gait training (treatment)Experimental Treatment1 Intervention
Group V: Device assisted ambulationExperimental Treatment1 Intervention
Group VI: Comparison to Standard PT (within subjects control)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northern Arizona University

Lead Sponsor

Trials
36
Recruited
6,300+

University of Washington

Collaborator

Trials
1,858
Recruited
2,023,000+

Gillette Children's Specialty Healthcare

Collaborator

Trials
31
Recruited
8,100+

Published Research Related to This Trial

A study involving 28 children with cerebral palsy showed significant improvements in ankle range of motion, strength, mobility, and balance after a 6-week robotic rehabilitation program, indicating the efficacy of this intervention.
The results from the clinic cohort were comparable to those from a previously published research cohort, demonstrating that robotic rehabilitation can be effectively implemented in a clinical setting for enhancing functional outcomes in children with cerebral palsy.
Clinical application of a robotic ankle training program for cerebral palsy compared to the research laboratory application: does it translate to practice?Sukal-Moulton, T., Clancy, T., Zhang, LQ., et al.[2021]
The ATLAS2030 exoskeleton significantly improved range of motion (ROM), strength, and reduced spasticity in three children with cerebral palsy after one month of robot-assisted gait training, indicating its potential as an effective rehabilitation tool.
All participants, aged around 8 years, were able to complete the training sessions, suggesting that the exoskeleton is user-friendly and can be integrated into therapy for children with varying levels of motor function.
ATLAS2030 Pediatric Gait Exoskeleton: Changes on Range of Motion, Strength and Spasticity in Children With Cerebral Palsy. A Case Series Study.Delgado, E., Cumplido, C., Ramos, J., et al.[2021]
The alpha-prototype of a novel pediatric ankle robot was developed to assist in the recovery of ankle function in children aged 5 to 8 years with cerebral palsy, indicating a targeted approach to rehabilitation for this specific age group and condition.
Pilot testing of the robot will begin at multiple children's hospitals, and initial data with healthy children suggests that the device has promising characteristics for effective therapy, following established design principles for robotic rehabilitation.
Pediatric anklebot.Krebs, HI., Rossi, S., Kim, SJ., et al.[2012]

Citations

Effects of ankle exoskeleton assistance and plantar ...Compared to incline walking without assistance or biofeedback, ankle assistance alone reduced the peak biological ankle moment by 12% (p < 0.001) ...
FOR RESEARCH | Biomotum Inc. | United StatesThe Biomotum SPARK is an untethered, go-anywhere research platform which provides dorsiflexion and plantarflexion assistance or resistance.
Robotic Ankle Therapy for Cerebral PalsyThe Biomotum Spark robotic ankle therapy is unique because it provides both assistance and resistance to the ankle, which can help improve strength and motor ...
Development of a Robotic Ankle Assist Device | ...Individuals with CP will participate in a 4-week assistance intervention and mobility outcomes will be quantified pre and post intervention. The second specific ...
5.biomotum.combiomotum.com/home
Robotics for Rehabilitation | Biomotum Inc. | United StatesThe Biomotum SPARK delivers precise and effective rehabilitation to individuals with cerebral palsy, stroke, and other neurological conditions. Increase ...
Evaluation of a Robotic Trainer for Children with Cerebral ...The purpose of this study to determine the safety and benefit of the BiOMOTUM RAAD robotic exoskeleton device to provide resistance as a tool ...
Walking on Real-world Terrain with an Ankle Exoskeleton ...Tested on an outdoor walking route with level, sloped, and stair terrain, robotic assistance resulted in a 15–18% (p = 0.013–0.026) reduction in estimated ...
Chief Science O icer NCT04516343 6/10/2024Title of Research Study: Development of robotic ankle assist device to improve mobility in individuals with movement disorders. Investigator Team Contact ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security